Upcoming Meetings: RAPS meetings
This article was originally published in The Gray Sheet
Executive Summary
RAPS meetings: Regulatory Affairs Professional Society schedules meeting on "Clinical Trials for Drugs, Devices and Biologics" Oct. 7-8 at the Sheraton City Centre Hotel in Washington, D.C. The meeting will address FDA's role in clinical trials, study design considerations, statistical approaches for data analysis, and how investigational review boards decide on study protocols. In addition, RAPS plans to hold a meeting on "Advertising, Labeling and Consumer Education" Oct. 28-29 at the Hyatt Regency in Bethesda, Maryland. Issues to be addressed include: direct-to-consumer advertising; promotion of off-label device and drug uses; promotion to managed care; and Internet advertising. For more information on either meeting, contact RAPS' education department at 301/770-2920 ext. 224/229...
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.